197
Views
3
CrossRef citations to date
0
Altmetric
Original Research

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis

ORCID Icon, , , , ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 633-645 | Published online: 02 Dec 2020

References

  • Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160.18331513
  • Canonica GW, Mullol J, Pradalier A, Didier A. Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in Europe and the United States. World Allergy Organ J. 2008;1(9):138–144. doi:10.1097/WOX.0b013e3181865faf23282577
  • Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(Suppl 85):17–25.
  • Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367–372. doi:10.1111/j.1398-9995.2006.01276.x17362246
  • de la Hoz Caballer B, Rodriguez M, Fraj J, Cerecedo I, Antolín-Amérigo D, Colás C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the cross-sectional study to evaluate work productivity in allergic rhinitis compared with other common diseases (CAPRI) study. Am J Rhinol Allergy. 2012;26(5):390–394. doi:10.2500/ajra.2012.26.379923168153
  • Perikleous E, Steiropoulos P, Nena E, et al. Association of asthma and allergic rhinitis with sleep-disordered breathing in childhood. Front Pediatr. 2018;6:250. doi:10.3389/fped.2018.0025030255006
  • Maoua M, Maalel OE, Kacem I, et al. Quality of life and work productivity impairment of patients with allergic occupational rhinitis. Tanaffos. 2019;18(1):58–65.31423142
  • Valls-Mateus M, Marino-Sanchez F, Ruiz-Echevarría K, et al. Nasal obstructive disorders impair health-related quality of life in adolescents with persistent allergic rhinitis: a real-life study. Pediatr Allergy Immunol. 2017;28(5):438–445. doi:10.1111/pai.1272428423474
  • Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274–1286 e9. doi:10.1016/j.jaip.2017.09.00229017832
  • Smith MP, Berdel D, Bauer CP, et al. Asthma and rhinitis are associated with less objectively-measured moderate and vigorous physical activity, but similar sport participation, in adolescent German boys: gINIplus and LISAplus cohorts. PLoS One. 2016;11(8):e0161461. doi:10.1371/journal.pone.016146127560942
  • Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy. 2012;26(2):120–122. doi:10.2500/ajra.2012.26.375222487288
  • Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381–387. doi:10.1016/j.jaci.2007.03.03417560637
  • Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc. 2009;30(4):358–365. doi:10.2500/aap.2009.30.324419772758
  • Su VY, Liu CJ, Lan MY, et al. Allergic rhinitis and risk of erectile dysfunction–a nationwide population-based study. Allergy. 2013;68(4):440–445. doi:10.1111/all.1210023346992
  • Vuurman EF, Vuurman LL, Lutgens I, Kremer B. Allergic rhinitis is a risk factor for traffic safety. Allergy. 2014;69(7):906–912. doi:10.1111/all.1241824815889
  • Berger WE. MP29-02 for the treatment of seasonal allergic rhinitis: a review of clinical pharmacology, efficacy and safety. Expert Rev Clin Immunol. 2013;9(9):803–811. doi:10.1586/1744666X.2013.82887624070043
  • Electronic Medicines Compendium. Dymista 137 micrograms/50 micrograms per actuation nasal spray, summary of product characteristics [updated December 10, 2019] Available from: www.medicines.org.uk/emc/product/9450/smpc. Accessed 929, 2020.
  • Kaulsay R, Nguyen DT, Kuhl HC. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy. Immun Inflamm Dis. 2018;6(4):456–464. doi:10.1002/iid3.23730306729
  • Klimek L, Bachert C, Stjärne P, et al. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: a pan-European study. Allergy Asthma Proc. 2016;37(5):376–386. doi:10.2500/aap.2016.37.397927657521
  • Price D, Klimek L, Gálffy G, et al. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma. Clin Mol Allergy. 2020;18:15. doi:10.1186/s12948-020-00130-932782442
  • Meltzer E, Ratner P, Bachert C, et al. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis. Int Arch Allergy Immunol. 2013;161(4):369–377. doi:10.1159/00035140423652808
  • Klimek L, Bergmann KC, Biedermann T, et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int. 2017;26(1):16–24.28217433
  • Bousquet J, Schünemann HJ, Hellings PW, et al.; MASK study group. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–374.e2. doi:10.1016/j.jaci.2016.03.025.27260321
  • Del Cuvillo A, Santos V, Montoro J, et al. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe. Rhinology. 2017;55(1):34–38. doi:10.4193/Rhin16.02528019644
  • Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105(2):168–173. doi:10.1016/j.anai.2010.06.00820674829
  • Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129(5):1282–1289.e10. doi:10.1016/j.jaci.2012.01.07722418065
  • Bousquet PJ, Combescure C, Klossek JM, Daurès JP, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol. 2009;123(6):1349–1354. doi:10.1016/j.jaci.2009.02.03319368963
  • Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013;43(8):881–888. doi:10.1111/cea.1212123889242
  • Klimek L, Poletti SC, Sperl A, et al. Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy. Int Forum Allergy Rhinol. 2017;7(3):287–292. doi:10.1002/alr.2187727888645
  • Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70–80.e3. doi:10.1016/j.jaci.2019.06.04931627910